Pre-made Etaracizumab biosimilar ( Whole mAb, anti-ITGAV_ITGB3 therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-195
Anti-ITGAV_ITGB3 therapeutic antibody (Pre-made Etaracizumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Etaracizumab, also known as etaratuzumab, MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-ITGAV_ITGB3 therapeutic antibody (Pre-made Etaracizumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Phase-II|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Applied Molecular Evolution;MedImmune|
|Conditions Discontinued||Colorectal cancer;Malignant melanoma;Prostate cancer;Psoriasis;Rheumatoid arthritis|